Fuzheng Huayu Tablets Against Posthepatitic Cirrhosis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2007
The primary purpose of the trial is adopted Fuzheng Huayu tablets against posthepatitic cirrhosis, and to build a standard evaluation system for efficacy of traditional Chinese medicine (TCM). The second purpose is according to the international clinical guideline and the specialty of TCM to build a standard clinical trial regulation for traditional Chinese medicine.
Epistemonikos ID: b5c547af7c1378a729809145acd09145331d0091
First added on: May 04, 2024